Cipla launches polymerase chain reaction test kit ‘ViraGen’ for Covid-19
Drug major Cipla on Thursday announced the commercialisation of its RT-PCR test kit ‘ViraGen’ for COVID-19 in India, in partnership with Ubio Biotechnology Systems.
“This launch will help address the current testing services and capacity issues while reaffirming the company’s ongoing expansion in the diagnostic space,” Cipla said in a regulatory filing.
Cipla will launch ViraGen test kit in the country in partnership with Ubio Biotechnology Systems, the company stated.
The company will commence supply of the COVID-19 virus detection kit from May 25, 2021.
Umang Vohra, MD and Global CEO, Cipla, said, “Cipla has been working relentlessly to ensure accessibility to treatments in this fight against COVID-19. Guided by our core purpose of ‘Caring for Life’, this partnership will enable us to reach out to more people across the country at a crucial time like now”.
Recent Posts
One Sleepless Night Can Weaken Your Immunity and Trigger Inflammation
Sleep is often regarded as a luxury in today’s fast-paced world, but scientific research continuously…
Thick Heart Syndrome: A Silent Threat to Millions in India
Heart disease remains one of the leading causes of death worldwide, and in India, cardiovascular…
Delhi Sees Surge in H1N1 and Influenza B Cases
Delhi is witnessing a sharp rise in flu cases, particularly Influenza B and H1N1 (commonly…
Woman Dies During MRI Scan Due to Medical Negligence
In early February 2025, a tragic incident occurred in Eluru, Andhra Pradesh, where a 61-year-old…
Holi and Eye Safety: Protect Your Vision During Festivities
Holi, the festival of colors, is one of the most vibrant and joyous celebrations in…
FDA Recalls Popular Skincare Products Over Cancer-Causing Chemical
In a major development, the U.S. Food and Drug Administration (FDA) has issued recalls for…